Equity Overview
Price & Market Data
Price: $3.11
Daily Change: +$0.11 / 3.54%
Daily Range: $2.95 - $3.30
Market Cap: $16,107,865
Daily Volume: 9,151
Performance Metrics
1 Week: 3.65%
1 Month: -4.31%
3 Months: -55.35%
6 Months: -57.97%
1 Year: -57.97%
YTD: -55.57%
Company Details
Employees: 10
Sector: Health technology
Industry: Biotechnology
Country: Israel
Details
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.